User profiles for Elliot Akama-Garren

Elliot Akama-Garren

Harvard Medical School
Verified email at hms.harvard.edu
Cited by 1173

[PDF][PDF] Metabolic modeling of single Th17 cells reveals regulators of autoimmunity

…, P Thakore, B Schellhaass, E Akama-Garren… - Cell, 2021 - cell.com
Metabolism is a major regulator of immune cell function, but it remains difficult to study the
metabolic status of individual cells. Here, we present Compass, an algorithm to characterize …

[PDF][PDF] Regulatory T cells in tumor-associated tertiary lymphoid structures suppress anti-tumor T cell responses

NS Joshi, EH Akama-Garren, Y Lu, DY Lee, GP Chang… - Immunity, 2015 - cell.com
Infiltration of regulatory T (Treg) cells into many tumor types correlates with poor patient
prognoses. However, mechanisms of intratumoral Treg cell function remain to be elucidated. We …

Rapid intraoperative molecular characterization of glioma

…, FW Huang, AS Venteicher, EH Akama-Garren… - JAMA …, 2015 - jamanetwork.com
Importance Conclusive intraoperative pathologic confirmation of diffuse infiltrative glioma
guides the decision to pursue definitive neurosurgical resection. Establishing the intraoperative …

CRISPR-mediated modeling and functional validation of candidate tumor suppressor genes in small cell lung cancer

…, WM Rideout III, EH Akama-Garren… - Proceedings of the …, 2020 - National Acad Sciences
Small cell lung cancer (SCLC) is a highly aggressive subtype of lung cancer that remains
among the most lethal of solid tumor malignancies. Recent genomic sequencing studies have …

Prior immunosuppressive therapy is associated with mortality in COVID‐19 patients: A retrospective study of 835 patients

EH AkamaGarren, JX Li - Journal of medical virology, 2021 - Wiley Online Library
Though it is widely believed that chronic immunosuppressive medications increase the
severity of coronavirus disease 2019 (COVID‐19) illness, there is little data to support this. We …

[HTML][HTML] p53 inhibitor iASPP is an unexpected suppressor of KRAS and inflammation-driven pancreatic cancer

P Miller, EH Akama-Garren, RP Owen… - Cell Death & …, 2023 - nature.com
Oncogenic KRAS activation, inflammation and p53 mutation are key drivers of pancreatic
cancer (PC) development. Here we report iASPP, an inhibitor of p53, as a paradoxical …

[HTML][HTML] A versatile reporter system for CRISPR-mediated chromosomal rearrangements

…, H Mou, C Colpan, A Bizhanova, E Akama-Garren… - Genome biology, 2015 - Springer
Although chromosomal deletions and inversions are important in cancer, conventional
methods for detecting DNA rearrangements require laborious indirect assays. Here we develop …

[HTML][HTML] A modular assembly platform for rapid generation of DNA constructs

EH Akama-Garren, NS Joshi, T Tammela, GP Chang… - Scientific reports, 2016 - nature.com
Traditional cloning methods have limitations on the number of DNA fragments that can be
simultaneously manipulated, which dramatically slows the pace of molecular assembly. Here …

Inducible de novo expression of neoantigens in tumor cells and mice

…, KA Connolly, GG Foster, E Akama-Garren… - Nature …, 2021 - nature.com
Inducible expression of neoantigens in mice would enable the study of endogenous antigen-specific
naïve T cell responses in disease and infection, but has been difficult to generate …

[HTML][HTML] Follicular T cells are clonally and transcriptionally distinct in B cell-driven mouse autoimmune disease

EH Akama-Garren, T van den Broek, L Simoni… - Nature …, 2021 - nature.com
Pathogenic autoantibodies contribute to tissue damage and clinical decline in autoimmune
disease. Follicular T cells are central regulators of germinal centers, although their …